62 related articles for article (PubMed ID: 21959309)
1. Claudin-5 as an immunohistochemical marker for angiosarcoma and hemangioendotheliomas.
Miettinen M; Sarlomo-Rikala M; Wang ZF
Am J Surg Pathol; 2011 Dec; 35(12):1848-56. PubMed ID: 21959309
[TBL] [Abstract][Full Text] [Related]
2. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D
Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397
[TBL] [Abstract][Full Text] [Related]
3. Vascular tumors of intermediate malignancy: An update.
Folpe AL
Hum Pathol; 2024 May; 147():114-128. PubMed ID: 38360216
[TBL] [Abstract][Full Text] [Related]
4. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.
Stiles JM; Amaya C; Rains S; Diaz D; Pham R; Battiste J; Modiano JF; Kokta V; Boucheron LE; Mitchell DC; Bryan BA
PLoS One; 2013; 8(3):e60021. PubMed ID: 23555867
[TBL] [Abstract][Full Text] [Related]
5. Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas.
Holczbauer Á; Gyöngyösi B; Lotz G; Szijártó A; Kupcsulik P; Schaff Z; Kiss A
J Histochem Cytochem; 2013 Apr; 61(4):294-305. PubMed ID: 23385421
[TBL] [Abstract][Full Text] [Related]
6. Primary vascular tumors of bone: A comprehensive literature review on classification, diagnosis and treatment.
Tortorelli I; Bellan E; Chiusole B; Murtas F; Ruggieri P; Pala E; Cerchiaro M; Buzzaccarini MS; Scarzello G; Krengli M; Bisinella G; Battisti S; Di Maggio A; Zagonel V; Tos APD; Sbaraglia M; Brunello A
Crit Rev Oncol Hematol; 2024 Mar; 195():104268. PubMed ID: 38237880
[TBL] [Abstract][Full Text] [Related]
7. The Profuse Bleeding Potential of Orbital Epithelioid Hemangioendotheliomas.
Jassar Z; Al Barazi R; Hourany R; Alameddine R
Ophthalmic Plast Reconstr Surg; 2024 May; ():. PubMed ID: 38722787
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Hemangioendothelioma: An update.
Virarkar M; Saleh M; Diab R; Taggart M; Bhargava P; Bhosale P
World J Gastrointest Oncol; 2020 Mar; 12(3):248-266. PubMed ID: 32206176
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of Claudin 4 in Gastric Adenocarcinomas.
Crețu OI; Stepan MD; Florescu MM; Stepan AE
Curr Health Sci J; 2022; 48(4):373-378. PubMed ID: 37304806
[TBL] [Abstract][Full Text] [Related]
10. Investigation of Prognostic Value of Claudin-5, PSMA, and Ki67 Expression in Canine Splenic Hemangiosarcoma.
Rozolen JM; Teodoro TGW; Sobral RA; Sueiro FAR; Laufer-Amorim R; Elias F; Fonseca-Alves CE
Animals (Basel); 2021 Aug; 11(8):. PubMed ID: 34438863
[TBL] [Abstract][Full Text] [Related]
11. Claudin expression profile in flat wart and cutaneous squamous cell carcinoma in epidermodysplasia verruciformis.
da Cruz Silva LL; de Oliveira WRP; Pereira NV; Halpern I; Tanabe CKD; Mattos MSG; Sotto MN
Sci Rep; 2020 Jun; 10(1):9268. PubMed ID: 32518268
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of digital image analysis as a supportive tool for the stratification of head and neck vascular anomalies.
Ehrenreich J; Bette M; Schmidt A; Roeßler M; Bakowsky U; Geisthoff UW; Stuck BA; Mandic R
Eur Arch Otorhinolaryngol; 2020 Oct; 277(10):2893-2906. PubMed ID: 32488381
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell Analysis of the Normal Mouse Aorta Reveals Functionally Distinct Endothelial Cell Populations.
Kalluri AS; Vellarikkal SK; Edelman ER; Nguyen L; Subramanian A; Ellinor PT; Regev A; Kathiresan S; Gupta RM
Circulation; 2019 Jul; 140(2):147-163. PubMed ID: 31146585
[TBL] [Abstract][Full Text] [Related]
14. aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability.
Riddell M; Nakayama A; Hikita T; Mirzapourshafiyi F; Kawamura T; Pasha A; Li M; Masuzawa M; Looso M; Steinbacher T; Ebnet K; Potente M; Hirose T; Ohno S; Fleming I; Gattenlöhner S; Aung PP; Phung T; Yamasaki O; Yanagi T; Umemura H; Nakayama M
Nat Commun; 2018 Dec; 9(1):5357. PubMed ID: 30559384
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology in retinal drug delivery.
Jiang S; Franco YL; Zhou Y; Chen J
Int J Ophthalmol; 2018; 11(6):1038-1044. PubMed ID: 29977820
[TBL] [Abstract][Full Text] [Related]
16. Expression of Tight Junction Components in Hepatocyte-Like Cells Differentiated from Human Embryonic Stem Cells.
Erdélyi-Belle B; Török G; Apáti Á; Sarkadi B; Schaff Z; Kiss A; Homolya L
Pathol Oncol Res; 2015 Sep; 21(4):1059-70. PubMed ID: 25845432
[TBL] [Abstract][Full Text] [Related]
17. A novel treatment for bone lesions of multifocal epithelioid sarcoma-like hemangioendothelioma.
Davis AT; Guo AM; Phillips NJ; Greenberg DD
Skeletal Radiol; 2015 Jul; 44(7):1013-9. PubMed ID: 25564226
[TBL] [Abstract][Full Text] [Related]
18. CD30 expression in malignant vascular tumors and its diagnostic and clinical implications: a study of 146 cases.
Alimchandani M; Wang ZF; Miettinen M
Appl Immunohistochem Mol Morphol; 2014; 22(5):358-62. PubMed ID: 24805132
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors.
Miettinen M; Rikala MS; Rys J; Lasota J; Wang ZF
Am J Surg Pathol; 2012 Apr; 36(4):629-39. PubMed ID: 22314185
[TBL] [Abstract][Full Text] [Related]
20. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
Miettinen M; Wang ZF
Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
